Free Trial

Intuitive Surgical (ISRG) Stock Forecast & Price Target

$400.89
-0.14 (-0.03%)
(As of 10:21 AM ET)

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 17 Analyst Ratings

Consensus Price Target

$396.17
-1.18% Downside
High Forecast$462.00
Average Forecast$396.17
Low Forecast$314.00
TypeCurrent Forecast
5/30/23 to 5/29/24
1 Month Ago
4/30/23 to 4/29/24
3 Months Ago
3/1/23 to 2/29/24
1 Year Ago
5/30/22 to 5/30/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
16 Buy rating(s)
15 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$396.17$396.17$371.60$300.50
Forecasted Upside-1.18% Downside12.95% Upside13.54% Upside11.13% Upside
Get Intuitive Surgical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Intuitive Surgical Stock vs. The Competition

TypeIntuitive SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.76
2.70
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside-1.21% Downside725.73% Upside10.84% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/19/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$425.00 ➝ $435.00+17.42%
4/19/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$412.00 ➝ $421.00+13.64%
4/19/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$440.00 ➝ $436.00+17.01%
4/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$365.00 ➝ $375.00+0.64%
4/8/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$420.00 ➝ $430.00+10.71%
4/3/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$428.00 ➝ $462.00+19.51%
1/25/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $390.00+4.78%
1/25/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$372.00 ➝ $435.00+17.55%
1/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$385.00 ➝ $430.00+16.19%
1/24/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$400.00 ➝ $432.00+18.42%
1/24/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$390.00 ➝ $435.00+18.59%
1/19/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$363.00 ➝ $416.00+11.85%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$300.00 ➝ $330.00+4.70%
11/17/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$318.00+4.62%
10/19/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$385.00 ➝ $314.00+14.82%
10/16/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$342.00+23.46%
7/21/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$335.00 ➝ $365.00+8.10%
5/31/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$350.00 ➝ $365.00+18.87%
4/19/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$245.00 ➝ $290.00-4.27%
4/19/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetInline$240.00 ➝ $270.00+0.27%
4/19/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$300.00 ➝ $315.00+16.98%
3/23/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
12/22/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$265.00 ➝ $320.00+20.23%
7/29/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$319.00 ➝ $273.00+18.37%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:40 AM ET.

ISRG Frequently Asked Questions

What is Intuitive Surgical's stock forecast and purchase recommendation?

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $396.17, with a high forecast of $462.00 and a low forecast of $314.00. The consensus rating for Intuitive Surgical stock is Moderate Buy based on the current 4 hold ratings and 13 buy ratings for ISRG. Learn more on ISRG's analyst rating history.

Do Wall Street analysts like Intuitive Surgical more than its competitors?

Analysts like Intuitive Surgical more than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.76 while the average consensus rating score for "medical" companies is 2.70. Learn more on how ISRG compares to other companies.

Does Intuitive Surgical's stock price have much upside?

According to analysts, Intuitive Surgical's stock has a predicted upside of 12.95% based on their 12-month stock forecasts.

What analysts cover Intuitive Surgical?

Intuitive Surgical has been rated by research analysts at BTIG Research, Citigroup, Jefferies Financial Group, Piper Sandler, Robert W. Baird, and Stifel Nicolaus in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:ISRG) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners